GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » ROE % Adjusted to Book Value

ENCell Co (XKRX:456070) ROE % Adjusted to Book Value : -10.78% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co ROE % Adjusted to Book Value?

ENCell Co's ROE % for the quarter that ended in Dec. 2024 was -41.30%. ENCell Co's PB Ratio for the quarter that ended in Dec. 2024 was 3.83. ENCell Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -10.78%.

ENCell Co ROE % Adjusted to Book Value Historical Data

The historical data trend for ENCell Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co ROE % Adjusted to Book Value Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - - - -9.22

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Dec23 Mar24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - -9.68 -10.78

Competitive Comparison of ENCell Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ENCell Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENCell Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ENCell Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ENCell Co's ROE % Adjusted to Book Value falls into.


;
;

ENCell Co ROE % Adjusted to Book Value Calculation

ENCell Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-35.30% / 3.83
=-9.22%

ENCell Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-41.30% / 3.83
=-10.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENCell Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ENCell Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
XKRX:060590 XKRX:083790 XKRX:011000 XKRX:353810 XKRX:127120 XKRX:376270 XKRX:086890 XKRX:203400 XKRX:278650 XKRX:234690 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
Website
http://www.encellinc.com
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines